WHENNovember 07, 2009 @ 8:00am - 5:00pm
WHERE
INFO
REGISTER

[nggallery id=64]

Forum Report Click Here

8:30 am Opening Remarks
Shuguang Zhu , CSO, AstaTech, Inc.; Co-Chair, SABPA Pacific Forum 2009
Xiangming Fang, SVP & CSO, eBioCenter; SABPA SD Chapter President & Board Member
8:40 am BIOCOM’s Asia Pacific Initiatives
Joseph Panetta, CEO, BIOCOM
8:50 am How to Profit in the World’s Fastest Growing Market – China
Ted Plafker, Sr. Writer, The Economist, Best-selling Author Doing Business in
China
9:20 am Panel Discussion: Pharmaceutical and Biotech Development around
Pacific Rim

Session Leader: Ming Guo, Chairman, Ascentage Pharma Slides
Chun-Lin Chen, CEO, Medicilon, Inc.
Mario Pennisi, CEO, Queensland Clinical Trials Network Inc. (Australia)Slides
Sean Wang, President, ITRI International (US presence of ITRI Taiwan)
Slides
Ian Wisenberg, SVP, Strategic Development, ChinaBio Slides

10:20 am Coffee Break and Networking
10:50 am Panel Discussion: Global Integrated R&D Strategies: East or West
Session Leader: Hui Li, Senior Principal Scientist, Pfizer Global R&D
Yun He, VP, BioDuro (Beijing) Co., Ltd.
Jing-Shan (Jennifer) Hu, Director, Licensing and External Research, Merck
Charles Huang, VP, Business Development, Sundia MediTech Company, Ltd.
Sylvie Sakata, Senior Director, External Research Solutions, Pfizer
Xiaoming Zou, Director, External Drug Discovery, GSK
11:50 am Suzhou Industrial Park (SIP) and BioBay Presentation
Session Leader: Hui Cai, VP, WUXI AppTec; Chair of Board, SABPA
Minglong Ma, Secretary, Suzhou Industrial Park Working Committee; Standing
Member, Suzhou Municipal Committee
Yuwen Liu, CEO, Suzhou BioBay
12:30 pm Lunch and Networking
1:30 pm Trend and Strategies of Venture Capital Funding in Biotech/Pharma
Industry

Ivor Royston, Founding Managing Partner, Forward Ventures
2:00 pm Sweeping Changes in IP Laws and the Impact on Life Science Companies
across the Pacific
Peng Chen, Partner, Morrison Foerster
2:30 pm Panel Discussion: What is your China Play – Doing Business in a
Shifting Regulatory, Investment, and Economic Environment
Slides

Session Leader: Zhu Shen, Pacific Forum Co-chair; CEO, BioForesight; Vice
Chairman and Board Member, SABPA
Stephen A. Bent, Partner, Foley & Lardner LLP
Jeffery Lange, VP, Business Development, SciClone Pharmaceuticals
Ben Wang, Esq., Senior Patent Counsel, Celera Corporation
3:30 pm Closing Remarks
Zhu Shen, Co-Chair, SABPA Pacific Forum 2009
3:30 – 4:30 pm Reception: Sponsored by Hillcrest Financial Group, LLC
Click here for the agenda (updated on 11/2/2009).

Click here for the speakers biography.